Privia Health Group, Inc.
Price Action
Technical Summary
CONSOLIDATINGPrivia Health Group, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 52), indicating performance broadly in line with the market. Earnings contraction of 22% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $22.26 | +6.35% | ABOVE |
| 50 SMA | $23.08 | +2.54% | ABOVE |
| 100 SMA | $22.60 | +4.72% | ABOVE |
| 150 SMA | $23.00 | +2.91% | ABOVE |
| 200 SMA | $23.30 | +1.61% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PRVA in an uptrend right now?
PRVA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is PRVA overbought or oversold?
PRVA's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is PRVA outperforming the market?
PRVA has a Relative Strength (RS) Rating of 52 out of 99. PRVA is performing about average compared to the market.
Where is PRVA in its 52-week range?
PRVA is trading at $23.67, which is 89% of its 52-week high ($26.51) and 63% above its 52-week low ($18.77).
How volatile is PRVA?
PRVA has a Beta of 0.80 and 52-week volatility of 33%. It's less volatile than the S&P 500 - generally more stable.